EUVIMEDEUVIMED entdecken
Crossref

Interferon‐α–Driven Stratification of B Cells Reveals Metabolic Reprogramming of Double‐Negative, Naïve, and Transitional Cell Subsets and Refines Molecular Classification in Sjögren's Disease

Cristian Iperi, Akhiya Anilkumar Rekha, Gustav Arvidsson, Gunnel Nordmark, Eleonore Bettacchioli, Marie Frutoso, Marta Alarcón-Riquelme, Jessica Nordlund, Ann-Christine Syvänen, PRECISESADS Flow Cytometry Study Group, PRECISESADS Clinical Consortium, Valérie Devauchelle-Pensec, Divi Cornec und 3 weitere

European Journal of Immunology · 2026-09 · 56 (9)

DOI: 10.1002/eji.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 27.09.2026. Verfasst von Cristian Iperi und 14 weiteren Autor:innen. Beteiligte Einrichtung: LBAI, UMR1227, Univ Brest, Inserm, Brest, France. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Interferon-alpha, B-Lymphocyte Subsets, B-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Innovative Medicines Initiative Joint Undertaking, Région Bretagne, Université de Brest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjögren's disease (SjD) is a chronic autoimmune condition marked by lymphocytic infiltration of exocrine glands and production of autoantibodies such as anti‐SSA/Ro, anti‐SSB/La, and rheumatoid factor. B lymphocytes play a central role in disease pathogenesis, driving autoantibody production and glandular damage, and contributing to lymphomagenesis. Despite promising therapies, no effective treatment is currently available, partly due to the biological and clinical heterogeneity of the disease. While interferon (IFN) signatures and B cell–related markers are used for patient stratification, their integration remains unexplored. This study analyzed B cell transcriptional and metabolic profiles using bulk transcriptomic, clinical, and flow cytometry data from the PRECISESADS consortium, alongside public single‐cell RNA‐sequencing datasets. A B cell–specific IFN‐α signature was established to stratify patients into IFN‐positive and IFN‐negative groups. Both showed reduced oxidative phosphorylation (OXPHOS) and translation in B cell subsets, suggesting a shared early metabolic reprogramming state. IFN‐positive patients, however, displayed additional features, including enhanced glycolysis, amino acid and lipid metabolism, autophagy, and NF‐κB signaling. They also showed an expansion of IFN‐activated‐naïve (naive IFN), Transitional, and double‐negative (DN) B cells, particularly DN2 and DN2_CXCR3 subsets, which have been linked in the literature to autoreactivity and lymphoma development. The IFN‐signature in naïve B cells and DN2 correlated with elevated anti‐SSA/Ro and anti‐SSB/La titers, while only naïve B cells showed an association with increased histological focus scores. These findings support B cell–specific IFN signature relevance in stratifying SjD patients and suggest new metabolic and transcriptional targets for disease monitoring and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeInterferon-alphaB-Lymphocyte SubsetsB-LymphocytesHumansMetabolic ReprogrammingTranscriptomeFemale

Stichwörter der Autor:innen

B lymphocyteInterferon signalingSjögren diseasemetabolismtranscriptomics

Substanzen

Interferon-alpha

Autor:innen und Institutionen

  • LBAI, UMR1227, Univ Brest, Inserm, Brest, France.
  • AltraBio SAS, Lyon, France.
  • Department of Medical Sciences, Molecular Precision Medicine, Uppsala University, Uppsala, Sweden.
  • Science For Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden.
  • CHU De Brest, Brest, France.

ORCID-Profile: Christophe Jamin

Förderung

  • Innovative Medicines Initiative Joint Undertaking
  • Région Bretagne
  • Université de Brest

Zitieren

APA

Iperi, C., Rekha, A. A., Arvidsson, G., Nordmark, G., Bettacchioli, E., Frutoso, M., Alarcón-Riquelme, M., Nordlund, J., Syvänen, A. C., PRECISESADS Flow Cytometry Study Group, PRECISESADS Clinical Consortium, Devauchelle-Pensec, V., Cornec, D., Hillon, S., Jamin, C., & Bordron, A. (2026). Interferon‐α–Driven Stratification of B Cells Reveals Metabolic Reprogramming of Double‐Negative, Naïve, and Transitional Cell Subsets and Refines Molecular Classification in Sjögren's Disease. European Journal of Immunology, 56(9). https://doi.org/10.1002/eji.70275

Vancouver

Iperi C, Rekha AA, Arvidsson G, Nordmark G, Bettacchioli E, Frutoso M, et al. Interferon‐α–Driven Stratification of B Cells Reveals Metabolic Reprogramming of Double‐Negative, Naïve, and Transitional Cell Subsets and Refines Molecular Classification in Sjögren's Disease. European Journal of Immunology. 2026;56(9). doi:10.1002/eji.70275

BibTeX
@article{Iperi2026,
  author = {Iperi, Cristian and Rekha, Akhiya Anilkumar and Arvidsson, Gustav and Nordmark, Gunnel and Bettacchioli, Eleonore and Frutoso, Marie and Alarcón-Riquelme, Marta and Nordlund, Jessica and Syvänen, Ann-Christine and PRECISESADS Flow Cytometry Study Group, PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Study Group, PRECISESADS Clinical Consortium and Devauchelle-Pensec, Valérie and Cornec, Divi and Hillon, Sophie and Jamin, Christophe and Bordron, Anne},
  title = {Interferon‐α–Driven Stratification of B Cells Reveals Metabolic Reprogramming of Double‐Negative, Naïve, and Transitional Cell Subsets and Refines Molecular Classification in Sjögren's Disease},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {9},
  doi = {10.1002/eji.70275}
}
Kostenlos starten →